Nvidia unveiled new tools designed to make it easier for hospitals to integrate AI models related to medical imaging into their clinical workflows. The tools have been adopted by major cloud infrastructure providers, as well as healthcare providers and AI software companies. Some of these include Cincinnati Children's Hospital, University of California San Francisco, England's National Health Service and Qure.ai.
"Whole-person care" is a term that gets thrown around a lot today, as a kind of virtue signaling for more personalized forms of care. But true whole-person care is not a buzzword; it's a complex delivery model that engages an integrated multidisciplinary team on the patient's behalf.
At Thyme Care, we believe that's the future of oncology care – but to get there, healthcare organizations must understand what whole-person care and a team-based approach really mean.
Don't miss out on your chance to save $800 and join us for exclusive networking opportunities and engaging content that highlights the opportunities and challenges the industry faces as it continues to evolve.
INVEST 2023 will unite innovative startups, active investors as well as forward-thinking healthcare providers, payers and life science companies.
By Amanda James Tuesday, November 29, 2022 9:32 PM
Dr. Akram Boutros said in a lawsuit filed Monday in Cuyahoga County court that Cleveland-based MetroHealth's board of directors violated open meeting laws when it "secretly hired" counsel to investigate him and then terminated him without mandatory public notice.
By Frank Vinluan Tuesday, November 29, 2022 5:57 PM
AstraZeneca is jumping into the chase for cell therapies that address solid tumors by acquiring Neogene Therapeutics. The startup's technology can be used to discover and develop novel targets that may be able to broaden the scope of cell therapies for cancer.
Nvidia unveiled new tools designed to make it easier for hospitals to integrate AI models related to medical imaging into their clinical workflows. The tools have been adopted by major cloud infrastructure providers, as well as healthcare providers and AI software companies. Some of these include Cincinnati Children's Hospital, University of California San Francisco, England's National Health Service and Qure.ai.
By Marissa Plescia Tuesday, November 29, 2022 5:34 PM
The funding round was led by Optum Ventures. Other investors include Adams Street Partners, Blue Shield of California and Humana. DispatchHealth will use the money to expand its capabilities in current markets, its CEO said.
By Valeria Fantin Tuesday, November 29, 2022 4:51 PM
We now see the next wave of potential cancer therapies on the horizon, propelled by significant advancements in immunology, as well as an increased understanding of tumor-driven mechanisms of immune evasion.
By Marina Record Tuesday, November 29, 2022 4:27 PM
As gene sequencing, machine learning, powerful imaging, sensors, gene and cell therapies make their way out of academic labs into everyday healthcare, our approach to healthcare is changing. For the first time, not only can we pinpoint the molecular and genetic causes of disease, but we also have the technologies to access them. On the back of this, prevention and cures are becoming possible. Can we afford them?
By Marissa Plescia Tuesday, November 29, 2022 4:12 PM
The average monthly premium for Medicare Advantage plans increased to $7 in the first half of the Medicare Annual Open Enrollment period this year, the eHealth report found. Premiums were in the $4 to $5 range for the last three years.
If the medical field wants to make serious progress on the Cancer Moonshot effort, it must expand its definition of personalized medicine and explore fresh approaches to cancer prevention, according to Dr. Siddhartha Mukherjee, a Pulitzer Prize-winning author and cancer physician at Columbia University Medical Center.
By Frank Vinluan Tuesday, November 29, 2022 12:28 PM
Tecentriq failed to beat chemotherapy in improving overall survival, the main goal of its confirmatory Phase 3 test in bladder cancer. The drug had been granted accelerated approval based on results from a single-arm Phase 2 clinical trial.
Among the takeaways from HLTH 2022 were the impact of consolidation on clinicians, behavioral health tools to help consumers manage stress and anxiety more productively, and how health tech and medtech companies are supporting remote patient monitoring and testing.
MedCity News 611 Broadway New York, NY 10012 United States
You received this email because you are subscribed to MedCity Daily Digest from MedCity News.
Update your email preferences to choose the types of emails you receive.
No comments